drugset / Trial / NCT01144702

Effectiveness of the Association Artesunate and Mefloquine in the Treatment of Malaria by Plasmodium Falciparum

NCT01144702

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study was to evaluate the effectiveness of the fixed combination of artesunate+mefloquine in the treatment of uncomplicated malaria caused by Plasmodium falciparum in the municipality of Cruzeiro do Sul, Juruá Valley, Brazil, where it was being used as specific first-line drug.

Timeline

Start
2010-11
Primary completion
2013-04
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Artesunate Small molecule 4 mg/kg Oral
Subject Mefloquine Unknown 8 mg/kg Oral